Report error Found 35 Enz. Inhib. hit(s) with all data for entry = 11797
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 200nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 5.10E+3nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 5.10E+3nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 5.10E+3nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 5.10E+3nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 5.10E+3nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 5.10E+3nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 5.10E+3nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 5.10E+3nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 5.10E+3nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 5.10E+3nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 5.10E+3nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Stingray Therapeutics
US Patent
Stingray Therapeutics
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Assay Buffer: 1 mM CaCl2), 0.2 mM ZnCl2, 50 mM Tris, pH 9.0. Substrate: 8 mM Thymidine 5′-monophosphate p-nitrophenol ester sodium salt (Sigma ...More data for this Ligand-Target Pair
